John M Lang

Title: John M Lang: Innovator in Protein Research

Introduction

John M Lang is a notable inventor based in Raleigh, NC (US), recognized for his contributions to the field of protein research. With a total of 2 patents, Lang has made significant strides in developing innovative methods and peptides that enhance the understanding and application of biologically active proteins.

Latest Patents

Lang's latest patents include groundbreaking work on alpha-1 proteinase inhibitor binding peptides. These peptides are designed to bind to alpha-1 Proteinase inhibitor (AlPI) and feature a variety of preferred sequences that enhance their binding capabilities. Additionally, he has developed a method for using these peptides in an affinity chromatography process to purify AlPI effectively. Another significant patent focuses on the selective stabilization of proteins during viral inactivation. This process involves a series of steps that allow for the viral inactivation of a solution containing biologically active proteins while preserving their functionality.

Career Highlights

John M Lang is currently associated with Bayer Corporation, where he continues to push the boundaries of protein research. His work has not only contributed to the scientific community but has also paved the way for advancements in therapeutic applications.

Collaborations

Lang has collaborated with esteemed colleagues such as George A Baumbach and Patrick D Bastek, further enriching his research endeavors and expanding the impact of his innovations.

Conclusion

John M Lang's contributions to protein research through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to influence advancements in biotechnology and therapeutic applications.